Skip to main content
. 2021 Jun 12;13(12):2950. doi: 10.3390/cancers13122950

Figure 4.

Figure 4

Kaplan–Meier survival curves according to TCR-β richness dynamics in anti-PD-1 treated NSCLC patients. (a) Progression-free survival (PFS) stratified in increased (n = 11) vs. decreased richness (n = 8). (b) Overall survival (OS) stratified in increased (n = 11) vs. decreased richness (n = 8). P-values were obtained using the log-rank test.